Investors

Since its inception, Ervaccine Technologies is financially supported by BPIFrance, Cancéropôle Lyon Auvergne-Rhône-Alpes and Agence Nationale de la Recherche.

End of 2020, a life science investor, Seventure (seed investment of 2.5 M€) joined the adventure!

“CLARA’s support will enable us to rapidly strengthen the resources set up for our therapeutic project.

We hope to be able to bring a first vaccine candidate into the clinic within two years,”